Indication: Infantile Spasms

A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and Pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms Patients

Sub-indication: Infantile Spasms

Drug Study

Principal Investigator: Vinay Puri, M.D.
Norton Children's Neuroscience Institute, affiliated with the UofL School of Medicine

Sponsor: Bio-Pharm Solutions Co., Ltd.

Search our entire site.